119 related articles for article (PubMed ID: 8107057)
1. Kinetics of appearance of intestinal lesions in mice mono-associated with a lethal or non-lethal strain of Clostridium difficile.
Castex F; Jouvert S; Bastide M; Corthier G
J Med Microbiol; 1994 Feb; 40(2):102-9. PubMed ID: 8107057
[TBL] [Abstract][Full Text] [Related]
2. Prevention of Clostridium difficile-induced experimental pseudomembranous colitis by Saccharomyces boulardii: a scanning electron microscopic and microbiological study.
Castex F; Corthier G; Jouvert S; Elmer GW; Lucas F; Bastide M
J Gen Microbiol; 1990 Jun; 136(6):1085-9. PubMed ID: 2200843
[TBL] [Abstract][Full Text] [Related]
3. Effect of toxins produced by various Clostridium difficile strains on cecum size reduction in gnotobiotic mice.
Mahé S; Corthier G
Can J Microbiol; 1988 Jul; 34(7):916-8. PubMed ID: 3143476
[TBL] [Abstract][Full Text] [Related]
4. Serogroup F strains of Clostridium difficile produce toxin B but not toxin A.
Depitre C; Delmee M; Avesani V; L'Haridon R; Roels A; Popoff M; Corthier G
J Med Microbiol; 1993 Jun; 38(6):434-41. PubMed ID: 8510136
[TBL] [Abstract][Full Text] [Related]
5. Effect of various diets on toxin production by two strains of Clostridium difficile in gnotobiotic mice.
Mahe S; Corthier G; Dubos F
Infect Immun; 1987 Aug; 55(8):1801-5. PubMed ID: 3610315
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxin and enterotoxin production by Clostridium difficile.
Gianfrilli P; Luzzi I; Pantosti A; Occhionero M; Gentile G; Panichi G
Microbiologica; 1984 Oct; 7(4):375-9. PubMed ID: 6513801
[TBL] [Abstract][Full Text] [Related]
7. Clostridium difficile--a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis.
Borriello SP; Ketley JM; Mitchell TJ; Barclay FE; Welch AR; Price AB; Stephen J
J Med Microbiol; 1987 Aug; 24(1):53-64. PubMed ID: 3612744
[TBL] [Abstract][Full Text] [Related]
8. Clostridium difficile toxins may augment bacterial penetration of intestinal epithelium.
Feltis BA; Kim AS; Kinneberg KM; Lyerly DL; Wilkins TD; Erlandsen SL; Wells CL
Arch Surg; 1999 Nov; 134(11):1235-41; discussion 1241-2. PubMed ID: 10555639
[TBL] [Abstract][Full Text] [Related]
9. Clostridium difficile toxins and enterococcal translocation in vivo and in vitro.
Feltis BA; Garni RM; Wells CL
J Surg Res; 2001 May; 97(1):97-102. PubMed ID: 11319888
[TBL] [Abstract][Full Text] [Related]
10. Detection of Clostridium difficile toxins from the small intestine and cecum of rabbits with naturally acquired enterotoxemia.
Perkins SE; Fox JG; Taylor NS; Green DL; Lipman NS
Lab Anim Sci; 1995 Aug; 45(4):379-84. PubMed ID: 7474876
[TBL] [Abstract][Full Text] [Related]
11. Pseudomembranous colitis in Clostridium difficile-monoassociated rats.
Czuprynski CJ; Johnson WJ; Balish E; Wilkins T
Infect Immun; 1983 Mar; 39(3):1368-76. PubMed ID: 6840842
[TBL] [Abstract][Full Text] [Related]
12. PCR-ribotyping and pyrolysis mass spectrometry fingerprinting of environmental and hospital isolates of Clostridium difficile.
Al-Saif NM; O'Neill GL; Magee JT; Brazier JS; Duerden BI
J Med Microbiol; 1998 Feb; 47(2):117-21. PubMed ID: 9879953
[TBL] [Abstract][Full Text] [Related]
13. A novel fusion protein containing the receptor binding domains of C. difficile toxin A and toxin B elicits protective immunity against lethal toxin and spore challenge in preclinical efficacy models.
Tian JH; Fuhrmann SR; Kluepfel-Stahl S; Carman RJ; Ellingsworth L; Flyer DC
Vaccine; 2012 Jun; 30(28):4249-58. PubMed ID: 22537987
[TBL] [Abstract][Full Text] [Related]
14. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro.
Riegler M; Sedivy R; Pothoulakis C; Hamilton G; Zacherl J; Bischof G; Cosentini E; Feil W; Schiessel R; LaMont JT
J Clin Invest; 1995 May; 95(5):2004-11. PubMed ID: 7738167
[TBL] [Abstract][Full Text] [Related]
15. Protection of hamsters against Clostridium difficile ileocaecitis by prior colonisation with non-pathogenic strains.
Borriello SP; Barclay FE
J Med Microbiol; 1985 Jun; 19(3):339-50. PubMed ID: 4009689
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterisation of toxin B from a strain of Clostridium difficile that does not produce toxin A.
Torres JF
J Med Microbiol; 1991 Jul; 35(1):40-4. PubMed ID: 1906544
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with parenteral toxoid B protects hamsters against lethal challenge with toxin A-negative, toxin B-positive clostridium difficile but does not prevent colonization.
Siddiqui F; O'Connor JR; Nagaro K; Cheknis A; Sambol SP; Vedantam G; Gerding DN; Johnson S
J Infect Dis; 2012 Jan; 205(1):128-33. PubMed ID: 22124129
[TBL] [Abstract][Full Text] [Related]
18. Toxin A-negative, toxin B-positive Clostridium difficile.
Drudy D; Fanning S; Kyne L
Int J Infect Dis; 2007 Jan; 11(1):5-10. PubMed ID: 16857405
[TBL] [Abstract][Full Text] [Related]
19. Toxin production by Clostridium difficile in a defined medium with limited amino acids.
Yamakawa K; Kamiya S; Meng XQ; Karasawa T; Nakamura S
J Med Microbiol; 1994 Nov; 41(5):319-23. PubMed ID: 7966203
[TBL] [Abstract][Full Text] [Related]
20. [Relation between isolation of bacteriophages from Clostridium difficile and cytotoxicity of the strains].
Bernabeu A; Iniesta A; Martín Luengo F
Enferm Infecc Microbiol Clin; 1991 May; 9(5):289-91. PubMed ID: 1954265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
